Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 08:09 am Purchase |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
AVORO CAPITAL ADVISORS LLC | 4,000,000 6.200% |
4,000,000 (New Position) |
Filing History |
| 2021-02-11 4:59 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 1,245,912 1.900% |
-1,188,784 (-48.83%) |
Filing History |
| 2021-02-08 10:27 am Purchase |
2021-02-05 | 13G | Kura Oncology, Inc. KURA |
FMR CORP | 9,116,040 13.821% |
2,318,838 (+34.11%) |
Filing History |
| 2021-02-03 2:29 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
Victory Capital Management, Inc. | 1,836,141 2.780% |
-538,445 (-22.68%) |
Filing History |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
BLACKROCK INC BLK |
4,931,956 7.600% |
1,938,204 (+64.74%) |
Filing History |
| 2021-01-28 4:41 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
WILSON TROY EDWARD | 2,190,379 3.300% |
-462,076 (-17.42%) |
Filing History |